CUSIP: G3141W106
What is CUSIP G3141W106?
CUSIP G3141W106 identifies EUCR - EUCRATES BIOMEDICAL ACQU COR - SHS in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP G3141W106:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q2 | 0 | $0 | -$2,985,299 | 0 | |
| 2023 Q1 | 294,343 | $2,985,299 | -$34,903 | $10.14 | 4 |
| 2022 Q4 | 297,836 | $2,975,806 | -$80,526,646 | $9.99 | 5 |
| 2022 Q3 | 8,434,647 | $84,541,805 | +$6,952,080 | $10.02 | 37 |
| 2022 Q2 | 7,746,847 | $76,681,000 | +$3,831,369 | $9.90 | 37 |
| 2022 Q1 | 7,435,252 | $73,191,000 | +$8,032,299 | $9.84 | 39 |
| 2021 Q4 | 6,619,128 | $64,600,984 | +$15,464,416 | $9.76 | 38 |
| 2021 Q3 | 5,118,549 | $50,060,000 | +$2,492,821 | $9.78 | 34 |
| 2021 Q2 | 4,863,023 | $47,876,000 | +$6,562,953 | $9.84 | 31 |
| 2021 Q1 | 4,195,714 | $41,762,000 | +$31,308,990 | $9.98 | 20 |
| 2020 Q4 | 985,691 | $9,906,000 | +$9,905,990 | $10.05 | 5 |